Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Shay Shemesh Insider Profile
4 Followers
Shay Shemesh, Chief Dev. & Ops. Officer at Nuvectis Pharma, holds 1.49M shares in Nuvectis Pharma (Ticker: NVCT). Most recently, Shay Shemesh Bought $1,113 shares of Nuvectis Pharma on May 13, 2024 for an estimated value of 7.03K.
Shay Shemesh Nuvectis Pharma (NVCT)Chief Dev. & Ops. Officer
Nuvectis Pharma (NVCT)
Chief Dev. & Ops. Officer
Ranked #5,933 out of 99,218 Corporate Insiders
Profitable Transactions
8 out of 12 Profitable Transactions
Average Return
+23.90%
Average return per transaction
Time Frame
Compare to
Insider Roles
Chief Dev. & Ops. Officer
Roles that Shay Shemesh holds in companies
Most Profitable Insider Trade
The most profitable trade made by Shay Shemesh
Shay Shemesh's Trading History
List of latest transactions for each holding click on a transaction to see Shay Shemesh's performance on stock
You May Also Like
Shay Shemesh insider profile FAQ
What is the percentage of profitable transactions made by Shay Shemesh?
The percentage of profitable transactions made by Shay Shemesh is 67%.
What is the average return per transaction made by Shay Shemesh?
The average return per transaction made by Shay Shemesh is 23.90%.
What stocks does Shay Shemesh hold?
Shay Shemesh holds: NVCT stocks.
What was Shay Shemesh’s latest transaction?
Shay Shemesh latest transaction was an Informative Buy of $7.03K.
What was Shay Shemesh's most profitable transaction?
Shay Shemesh’s most profitable transaction was an Informative Buy of NVCT stock on September 27, 2022. The return on the trade was 87.40%.
What is Shay Shemesh's role in Nuvectis Pharma?
Shay Shemesh's role in Nuvectis Pharma is Chief Dev. & Ops. Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.